2020 Annual Meeting Scientific Program Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Stock and Other Travel, (OPTIONAL) Consulting or Advisory Patents, Royalties, Other Expert Other Name Employment Leadership Ownership Honoraria Speakers' Bureau Research Funding Accommodations, Uncompensated Role Intellectual Property Testimony Relationship Interests Expenses Relationships Howard A. Burris III HCA Healthcare / HCA Healthcare HCA Healthcare / AstraZeneca (Inst), Agios (Inst), Arch (Inst), Arvinas (Inst), Novartis Sarah Cannon / Sarah Cannon Sarah Cannon Boehringer Ingelheim AstraZeneca (Inst), BioAtla (Inst), (Inst), Bristol-Myers BioMed Valley Discoveries (Inst), Squibb (Inst), Celgene Boehringer Ingelheim (Inst), Bristol- (Inst), Eisai (Inst), FORMA Myers Squibb (Inst), Celgene (Inst), Therapeutics (Inst), Incyte CicloMed (Inst), CytomX Therapeutics (Inst), Janssen (Inst), (Inst), eFFECTOR Therapeutics MedImmune (Inst), (Inst), Gilead Sciences (Inst), Mersana (Inst), Novartis GlaxoSmithKline (Inst), Harpoon (Inst), Roche/Genentech Therapeutics (Inst), Immunocore (Inst), Tolero (Inst), Incyte (Inst), Janssen (Inst), Pharmaceuticals (Inst) Jiangsu Hengrui Medicine (Inst), Jounce Therapeutics (Inst), Kyocera (Inst), Lilly (Inst), Loxo (Inst), Macrogenics (Inst), MedImmune (Inst), Merck (Inst), Millennium (Inst), Moderna Therapeutics (Inst), Novartis (Inst), Revolution Medicines (Inst), Roche/Genentech (Inst), Seattle Genetics (Inst), Takeda (Inst), Tesaro (Inst), TG Therapeutics (Inst), Verastem (Inst), Vertex (Inst) Suzanne George Abbott Laboratories, Bayer, Blueprint ARIAD (Inst), Bayer (Inst), Blueprint UptoDate Bayer Research to Abbvie (I), Allergan Medicines, Deciphera, Medicines (Inst), Deciphera (Inst), Practice (I) Lilly, MORE Health, Novartis (Inst), Pfizer (Inst) Research to Practice, UpToDate Norah L. Henry Abbvie (Inst), Innocrin Pharma (Inst), Pfizer (Inst) Melissa L. Johnson Araxes Pharma (Inst), Abbvie (Inst), Acerta Pharma (Inst), Abbvie, Astellas Astellas Pharma (I), Adaptimmune (Inst), Amgen (Inst), Pharma, AstraZeneca, AstraZeneca (Inst), Array BioPharma (Inst), AstraZeneca Boehringer Ingelheim, BeiGene (Inst), (Inst), BeiGene (Inst), BerGenBio Bristol-Myers Squibb, Boehringer Ingelheim (Inst), Birdie (Inst), Boehringer Clovis Oncology, Daiichi (Inst), Bristol-Myers Ingelheim (Inst), Bristol-Myers Squibb Sankyo, EMD Serono, Squibb (Inst), Calithera (Inst), Checkpoint Therapeutics (Inst), Exelixis, Genentech, Biosciences (Inst), Clovis Oncology (Inst), Corvus Incyte, Merck, Pfizer, Celgene (Inst), Pharmaceuticals (Inst), CytomX Sysmex, Vapotherm Genentech/Roche (Inst), Therapeutics (Inst), Daiichi Sankyo Guardant Health (Inst), (Inst), Dynavax (Inst), EMD Serono Incyte (Inst), Loxo (Inst), (Inst), Foundation Medicine (Inst), G1 Merck (Inst), Mersana Therapeutics (Inst), (Inst), Mirati Therapeutics Genentech/Roche (Inst), Genmab (Inst), Otsuka (I), Pfizer (Inst), Genocea Biosciences (Inst), (Inst), Ribon Therapeutics GlaxoSmithKline (Inst), Gritstone (Inst), Sanofi (Inst) Oncology (Inst), Guardant Health (Inst), Hengrui Pharmaceutical (Inst), Incyte (Inst), Janssen (Inst), Kadmon (Inst), Lilly (Inst), Loxo (Inst), Lycera (Inst), Merck (Inst), Mersana (Inst), Mirati Therapeutics (Inst), Neovia Oncology (Inst), Novartis (Inst), OncoMed (Inst), Pfizer (Inst), Regeneron (Inst), Sanofi (Inst), Shattuck Labs (Inst), Stem CentRx (Inst), Syndax (Inst), Takeda (Inst), Tarveda Therapeutics (Inst) Biostatistics Karla V. Ballman Agenus, ARIAD, Prostate cancer signature Janssen Medtronic, Takeda patent (Inst), Immune Oncology, Lilly enrichment signature for response to trastuzumab in HER2+ breast cancer (Inst) Thomas Braun Johnson & OncoImmune Johnson (I) Suzanne E. AstraZeneca Patent pending for a Dahlberg statistical model assessing tumor growth (Inst) Rosemarie Mick Editas Medicine Infiniti Medical Mary W. Redman Ignyta Yu Shyr Aduro Biotech, Royalty for TNBCType for GlaxoSmithKline, Janssen Insight Genetics. TNBCType Research & Development, is a web-based subtyping Novartis, Pfizer, tool TNBCtype for candidate Roche/Genentech TNBC samples using our gene expression meta data and classification method. Nolan Wages Abbvie (Inst) Breast Cancer - Metastatic Adam Brufsky Agendia, Bayer, Bioarray Therapeutics, BioTheranostics, Celgene, Eisai, Genentech/Roche, Genomic Health, Lilly, Merck, Myriad Pharmaceuticals, NanoString Technologies, Novartis, Pfizer, Puma Biotechnology Roisin M. Connolly Genentech/Roche (Inst), Macrogenics Genentech/Roche, (Inst), Merck (Inst), Merrimack (Inst), Syndax Novartis (Inst), Puma Biotechnology (Inst) Olwen M. Hahn Via Oncology Cardinal Health (I) Pfizer Cardinal Health (I) Erika P. Hamilton Boehringer Ingelheim Abbvie (Inst), Acerta Pharma (Inst), Amgen, AstraZeneca, (Inst), Cascadian ArQule (Inst), AstraZeneca (Inst), Bayer, Bristol-Myers Therapeutics (Inst), BerGenBio (Inst), Boehringer Squibb, Clovis Daiichi Sankyo (Inst), Ingelheim (Inst), Cascadian Oncology, Eisai, EMD Eisai (Inst), Therapeutics (Inst), Clovis Oncology Serono, Foundation Genentech/Roche (Inst), (Inst), Curis (Inst), CytomX Medicine, Genentech, Lilly (Inst), Mersana (Inst), Therapeutics (Inst), Daiichi Sankyo Genentech/Roche, Pfizer (Inst), Puma (Inst), Deciphera (Inst), eFFECTOR Genzyme, Guardant Biotechnology (Inst) Therapeutics (Inst), Eisai (Inst), EMD Health, Helsinn Serono (Inst), Fujifilm (Inst), Therapeutics, HERON, Genentech/Roche (Inst), H3 Lexicon, Lilly, Biomedicine (Inst), Hutchison Medivation, Merck, MediPharma (Inst), Immunomedics Novartis, Pfizer, Roche, (Inst), InventisBio (Inst), Kadmon Sysmex, Tesaro (Inst), Leap Therapeutics (Inst), Lilly (Inst), Lycera (Inst), Macrogenics (Inst), Mallinckrodt (Inst), MedImmune (Inst), Medivation (Inst), Mersana (Inst), Merus (Inst), Millennium (Inst), Novartis (Inst), Nucana (Inst), OncoMed (Inst), Oncothyreon (Inst), Pfizer (Inst), PharmaMar (Inst), Radius Health (Inst), Regeneron (Inst), Rgenix (Inst), Stem CentRx (Inst), Syndax (Inst), Syros Pharmaceuticals (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), TapImmune (Inst), Tesaro (Inst), TetraLogic Pharmaceuticals (Inst), Verastem (Inst), Zymeworks (Inst) Elizabeth C. Reed Pfizer Pfizer/NCCN Nicholas C. Turner AstraZeneca, Bicycle AstraZeneca (Inst), Bio-Rad (Inst), Therapeutics, Bristol- Clovis Oncology (Inst), Guardant Myers Squibb, Lilly, Merck Health (Inst), Pfizer (Inst), Roche Sharp & Dohme, Novartis, (Inst) Pfizer, Roche, Tesaro Breast Cancer -Local/Regional/Adjuvant Lior Z. Braunstein Naamit K. Gerber OncLive Eun-Sil S. Hwang Henry M. Kuerer Cardinal Health, Genomic PER Genomic Health (Inst) NEJM Group, McGraw-Hill Health, Targeted Medical Publishing Education Erica L. Mayer Context Therapeutics, Myriad Genetics (Inst), Pfizer (Inst) Eisai, Lilly, Novartis, Pfizer Vered Stearns Iridium Therapeutics Abbvie, Biocept, MedImmune, Immunomedics Novartis, Pfizer, Puma Biotechnology Richard C. Zellars Cancer Prevention, Risk Reduction, and Genetics John R. Goffin Amgen, Boehringer AstraZeneca Ingelheim, Bristol-Myers Squibb, Merck Erin W. Hofstatter UpToDate Andrew McKenzie Mark E. Robson AstraZeneca AstraZeneca, McKesson Abbvie (Inst), AstraZeneca (Inst), AstraZeneca, Pfizer Clinical Care Daiichi Sankyo, Merck, InVitae (Inst), Medivation (Inst), Options, Physician Pfizer Myriad Genetics (Inst), Tesaro (Inst) Education Resource, Research to Practice Nadine M. Tung AstraZeneca Care Delivery and Regulatory Policy Adam P. Dicker American Oncohost Apex, Celldex, Cybrexa Prostate Cancer Foundation We recently filed a patient: Wilson, Socini EMD Serono, Ferring, Dreamit Ventures Google Society for Therapeutics, EMD "doped beo compounds for Merck, Self Care Radiation Serono, Janssen, optically stimulated Catalyst Oncology, Johnson & Johnson, luminescence (OSL) and Department of Oncohost, Roche, Self thermoluminescence (TL) Defense- Care Catalyst, Thirdbridge radiation dosimetry" Prostate Cancer Research Program, NRG Oncology Lynn J. Howie Ipsen National Breast Cancer Coalition Richard T. Lee Tracon (Inst) Grow Ohio Pharmaceuticals Enrique Soto Perez Roche (I) De Celis Ari Vanderwalde Bristol-Myers Squibb, Amgen (Inst), Merck (Inst), Genentech/Roche, Caris Genentech/Roche (Inst), Millennium Life Sciences, Compugen, (Inst), AstraZeneca (Inst), Polynoma Immunocore, Concerto (Inst), Lilly (Inst), Bristol-Myers Squibb Health-AI, Elsevier (Inst), Amgen (Inst), Replimune (Inst), Caris Life Sciences (Inst), EMD Serono (Inst) Central Nervous System Tumors E. Antonio Chiocca DNAtrix Merck Advantagene, Alcyone Amgen Patents related to oncolytic Lifesciences, DNAtrix, virus technology, gene Insigthec, NanoTX, therapy, microRNA, Oncorus, Sigilon, exosome, antibodies StemGen, Tocagen, ZIOPHARM Oncology Timothy F. Notable Labs Abbvie, Agios, Alexion U.S. Provisional Application Global Coalition for Cloughesy Pharmaceuticals, Bayer, No.: 62/819,322 Adaptive Research Boehringer Ingelheim, Title: COMPOSITIONS AND 501(c)(3) Boston Biomedical, Bristol- METHODS FOR TREATING Myers Squibb, Celgene, CANCER Cortice, Deciphera, Filing Date: March 15, 2019 DelMar Pharmaceuticals, Inventor(s): David A. Genocea Biosciences, Nathanson et al. GW Pharmaceuticals, FH Reference No.: UCH- Human Longevity, Insys 17760 (32246-17760) Therapeutics, KIYATEC, Your Reference No.: [UCLA Lilly, Merck, NewGen 2019-630-1] US Therapeutics, Notable Labs, Novartis, Novocure, Novogen, Oxigene, Pfizer, Puma Biotechnology, Roche/Genentech, Sunovion, Tocagen,